Price $4.34 |
Market Cap
137M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.39
|
P/S
2.47
|
Dividend %
-
|
|
P/CF
5.7
|
P/FCF
-
|
Op. Cash Flow
-68.1K
|
FCF
-2.1
|
|
Op. Margin
-68.30%
|
Net Margin
-59.70%
|
ROE
-28.40%
|
ROI
-11.50%
|
|
ROA
-13.10%
|
EPS Growth
-516.60%
|
Current Ratio
4.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acorda Therapeutics Inc (ACOR) | $12.93 | - | - | 790.9M | Strong Buy |
| Quorum Health Corp (QHC) | $2.54 | - | - | 92.4M | Strong Buy |
| Harrow Health Inc (HROW) | $6.76 | - | - | 138.7M | Strong Buy |
| Horizon Pharma PLC (HZNP) | $21.20 | - | - | 3.6B | Strong Buy |
| IRIDEX Corporation (IRIX) | $4.77 | - | - | 64.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
